Literature DB >> 15717664

Severe hyperglycemia associated with electroconvulsive therapy.

S Dagdelen, A Akin-Atmaca, A Gürlek, A Tufan, E Güven, E Anil-Yagcioglu.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15717664     DOI： 10.1007/BF03347489

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  Atypical neuroleptics and diabetes.

Authors:  S Béliard; R Valero; B Vialettes
Journal:  Diabetes Metab       Date:  2003-06       Impact factor: 6.041

2.  Significant rise in plasma insulin after electroconvulsive therapy.

Authors:  G E Berrios; A Bulbena; A R Martinez; D Ortega Gazo; J M Castellanos Llorens; C D Lozano
Journal:  Acta Psychiatr Scand       Date:  1986-08       Impact factor: 6.392

3.  The effects of electroconvulsive therapy on plasma insulin and glucose in depression.

Authors:  K Williams; J Smith; P Glue; D Nutt
Journal:  Br J Psychiatry       Date:  1992-07       Impact factor: 9.319

4.  Safety, efficacy, and effects on glycemic control of electroconvulsive therapy in insulin-requiring type 2 diabetic patients.

Authors:  Pamela J Netzel; Paul S Mueller; Teresa A Rummans; Keith G Rasmussen; V Shane Pankratz; Christine M Lohse
Journal:  J ECT       Date:  2002-03       Impact factor: 3.635

5.  Effect of glucose on the glucagon response after the electroconvulsive therapy in man.

Authors:  I Klimes; J Jurcovicová; J Benetinová; M Vigăs; V Wiedermann
Journal:  Horm Metab Res       Date:  1980       Impact factor: 2.936

6.  Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

Authors:  Frank Gianfrancesco; Amy Grogg; Ramy Mahmoud; Ruey Hua Wang; Dennis Meletiche
Journal:  Clin Ther       Date:  2003-04       Impact factor: 3.393
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.